Tobacco and coffee contain bioactive compounds that may reduce Parkinson's disease risk by targeting key pathways such as MAO ...
I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision ...
Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, ...
Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...
I-Mab, a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment ...
Skin allergies are often worsened by psychological stress, but the underlying mechanisms remain poorly understood.
The journey of a thousand miles begins with a single step, but for developing neurons, this first step relies on ...
Naya Biosciences Inc. has expanded its bifunctional antibody pipeline to include NY-500, a novel PD-1 x VEGF tetravalent bifunctional antibody for the treatment of hepatocellular carcinoma (HCC) and ...
A research team from the University of California, Irvine has revealed a previously unknown mechanism that triggers an inflammatory immune response in cells when their DNA is damaged.
The ERBB-receptor network is one of the most extensively studied areas of signal ... AKT/PKB pathway. ERBB1 signalling is negatively regulated through ubiquitylation by Cbl. Figure 1: A systems ...